Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · IEX Real-Time Price · USD
0.871
+0.010 (1.16%)
At close: May 2, 2024, 2:17 PM
0.880
+0.009 (1.03%)
After-hours: May 2, 2024, 4:56 PM EDT
Xtant Medical Holdings Revenue
In the year 2023, Xtant Medical Holdings had annual revenue of $91.30M with 57.50% growth. Revenue in the quarter ending December 31, 2023 was $28.11M with 84.07% year-over-year growth.
Revenue (ttm)
$91.30M
Revenue Growth
+57.50%
P/S Ratio
1.23
Revenue / Employee
$441,077
Employees
207
Market Cap
112.49M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 91.30M | 33.33M | 57.50% |
Dec 31, 2022 | 57.97M | 2.71M | 4.90% |
Dec 31, 2021 | 55.26M | 1.93M | 3.61% |
Dec 31, 2020 | 53.34M | -11.35M | -17.54% |
Dec 31, 2019 | 64.68M | -7.52M | -10.42% |
Dec 31, 2018 | 72.20M | -10.41M | -12.60% |
Dec 31, 2017 | 82.61M | -7.39M | -8.21% |
Dec 31, 2016 | 90.00M | 30.66M | 51.66% |
Dec 31, 2015 | 59.35M | 24.01M | 67.97% |
Dec 31, 2014 | 35.33M | 2.26M | 6.83% |
Dec 31, 2013 | 33.07M | 93.52K | 0.28% |
Dec 31, 2012 | 32.98M | 2.83M | 9.39% |
Dec 31, 2011 | 30.15M | 14.73M | 95.55% |
Dec 31, 2010 | 15.42M | 8.02M | 108.53% |
Dec 31, 2009 | 7.39M | 6.93M | 1,509.98% |
Dec 31, 2008 | 459.23K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
TruBridge | 339.44M |
FibroGen | 147.75M |
Karyopharm Therapeutics | 146.03M |
Abeona Therapeutics | 3.50M |
GlycoMimetics | 10.00K |
XTNT News
- 2 days ago - Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds - GlobeNewsWire
- 4 weeks ago - Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million - GlobeNewsWire
- 6 weeks ago - Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024 - GlobeNewsWire
- 2 months ago - Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial - GlobeNewsWire
- 2 months ago - Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 6 months ago - Xtant Medical to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - Xtant Medical Announces Record Third Quarter Revenue of $25 Million - GlobeNewsWire
- 6 months ago - Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical - GlobeNewsWire